Mental Health
Fluoroquinolone Warnings for Mental Health, Hypoglycemia Risks are Updated
Fluoroquinolone Warnings for Mental Health, Hypoglycemia Risks are Updated
Officials with the FDA are requiring safety label updates for fluoroquinolone antibiotics due to risks of mental health adverse effects, and blood sugar disturbances.
Read More >>
Schizophrenia Regimen Approved by FDA
5 Ways Pharmacists Can Help Prevent Suicide
A Video Game to Create Empathy
Dextromethorphan Studied for Use In Bipolar Disorder
ASD and Medication Adherence: An Opportunity for Pharmacist Intervention
FDA OKs Lurasidone for Use as Bipolar Medication in Children
The Science Behind Pharmacist Burnout Is Scary: Here Is What to Do About It
View more articles >>
Clinical Trials
Modeling Multi-level Dyadic Behavior to Transform the Science and Practice of Psychotherapy Process and Outcome.
Transcranial Magnetic Stimulation in Primary Progressive Aphasia
Tobacco Intensive Motivational and Estimate Risk
Micronutrients as Adjunctive Treatment for Bipolar Disorder
Controlled Study of Chain Blanket for Insomnia
Multimedia: Videos
Clinical Profile of a Patient With Serious Mental Illness
Clinical Profile of a Patient With Serious Mental Illness
Defining Serious Mental Illness
Defining Serious Mental Illness
Introduction to Bipolar Disorder with John Zajecka, MD
Introduction to Bipolar Disorder with John Zajecka, MD
Frederick K. Goodwin, MD - Understanding Bipolar Disorder and Its Treatment: An Update
Frederick K. Goodwin, MD - Understanding Bipolar Disorder and Its Treatment: An Update